Mechano-Therapeutics
Philadelphia-based medical firm specializing in advanced drug delivery systems for enhanced therapy.
Founded
2021Philadelphia-based medical firm specializing in advanced drug delivery systems for enhanced therapy.
Mechano-Therapeutics, founded as a spin-out from the University of Pennsylvania, is a Philadelphia-based medical firm dedicated to revolutionizing musculoskeletal health through advanced drug delivery systems. The company’s core mission is to enhance therapeutic performance using innovative microcapsule technology. Their primary focus is on developing and commercializing these cutting-edge drug delivery solutions to improve patient outcomes in the musculoskeletal health market.
Notable affiliated individuals include researchers and experts from the University of Pennsylvania, contributing to the company's strong scientific foundation. Mechano-Therapeutics has garnered attention from investors interested in pioneering medical technologies. Key achievements include successful preclinical trials demonstrating the efficacy of their microcapsule drug delivery systems. The company’s impact lies in its potential to significantly improve treatment protocols and patient care in musculoskeletal health.
Companies similar to Mechano-Therapeutics include Mekanistic Therapeutics, Talima Therapeutics, Enable Therapeutics and Concept Matrix Solutions.
Mechano-Therapeutics was founded in 2021.
Mechano-Therapeutics' headquarters is located in Philadelphia, PA, US.
Mechano-Therapeutics' most recent funding round was for $800k (USD) in June 2023.
As of Jun 1, 2023, Mechano-Therapeutics has disclosed funding of $800k (USD). Undisclosed round amounts are excluded.
Mechano-Therapeutics has 9 employees as of Feb 4, 2024.
Concept Matrix Solutions
